Balamurugan A - Search Results

1

Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination.

Balamurugan A, Lewis MJ, Kitchen CM, Robertson MN, Shiver JW, Daar ES, Pitt J, Ali A, Ng HL, Currier JS, Yang OO. Balamurugan A, et al. J Virol. 2008 Mar;82(6):2784-91. doi: 10.1128/JVI.01720-07. Epub 2008 Jan 16. J Virol. 2008. PMID: 18199650 Free PMC article.

2

Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.

Yang OO, Daar ES, Jamieson BD, Balamurugan A, Smith DM, Pitt JA, Petropoulos CJ, Richman DD, Little SJ, Brown AJ. Yang OO, et al. Among authors: balamurugan a. J Virol. 2005 Jan;79(2):860-8. doi: 10.1128/JVI.79.2.860-868.2005. J Virol. 2005. PMID: 15613314 Free PMC article.

3

Nef interference with HIV-1-specific CTL antiviral activity is epitope specific.

Adnan S, Balamurugan A, Trocha A, Bennett MS, Ng HL, Ali A, Brander C, Yang OO. Adnan S, et al. Among authors: balamurugan a. Blood. 2006 Nov 15;108(10):3414-9. doi: 10.1182/blood-2006-06-030668. Epub 2006 Aug 1. Blood. 2006. PMID: 16882705 Free PMC article.

4

Functional adaptation of Nef to the immune milieu of HIV-1 infection in vivo.

Lewis MJ, Balamurugan A, Ohno A, Kilpatrick S, Ng HL, Yang OO. Lewis MJ, et al. Among authors: balamurugan a. J Immunol. 2008 Mar 15;180(6):4075-81. doi: 10.4049/jimmunol.180.6.4075. J Immunol. 2008. PMID: 18322217

5

Rapid T cell receptor delineation reveals clonal expansion limitation of the magnitude of the HIV-1-specific CD8+ T cell response.

Balamurugan A, Ng HL, Yang OO. Balamurugan A, et al. J Immunol. 2010 Nov 15;185(10):5935-42. doi: 10.4049/jimmunol.1002236. Epub 2010 Oct 13. J Immunol. 2010. PMID: 20944001 Free PMC article.

6

Antiviral activity of human immunodeficiency virus type 1 Gag-specific cytotoxic T lymphocyte targeting is not necessarily intrinsically superior to envelope targeting.

Chen DY, Balamurugan A, Ng HL, Yang OO. Chen DY, et al. Among authors: balamurugan a. J Virol. 2011 Mar;85(5):2474-8. doi: 10.1128/JVI.01726-10. Epub 2010 Dec 15. J Virol. 2011. PMID: 21159882 Free PMC article.

7

Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.

Chen DY, Balamurugan A, Ng HL, Cumberland WG, Yang OO. Chen DY, et al. Among authors: balamurugan a. Blood. 2012 Jul 5;120(1):100-11. doi: 10.1182/blood-2012-02-409870. Epub 2012 May 21. Blood. 2012. PMID: 22613796 Free PMC article.

8

HIV-1 gag cytotoxic T lymphocyte epitopes vary in presentation kinetics relative to HLA class I downregulation.

Balamurugan A, Ali A, Boucau J, Le Gall S, Ng HL, Yang OO. Balamurugan A, et al. J Virol. 2013 Aug;87(15):8726-34. doi: 10.1128/JVI.01040-13. Epub 2013 Jun 5. J Virol. 2013. PMID: 23740989 Free PMC article.

9

HIV-1 Epitope Variability Is Associated with T Cell Receptor Repertoire Instability and Breadth.

Balamurugan A, Claiborne D, Ng HL, Yang OO. Balamurugan A, et al. J Virol. 2017 Jul 27;91(16):e00771-17. doi: 10.1128/JVI.00771-17. Print 2017 Aug 15. J Virol. 2017. PMID: 28592539 Free PMC article.

10

Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones.

Balamurugan A, Ng HL, Yang OO. Balamurugan A, et al. J Virol. 2018 Jul 31;92(16):e00617-18. doi: 10.1128/JVI.00617-18. Print 2018 Aug 15. J Virol. 2018. PMID: 29899094 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters